Clinical trial Recruiting at 4 sites Interventional Ages 40 to 85

Rehabilitation training using music for COPD and chronic respiratory failure patients

Official title: Can Rehabilitation Training With Music-support Increase Exercise Tolerance in Individuals With COPD and CRF Compared to Rehabilitation Training Alone? A Randomized Control Trial.

Run by Istituti Clinici Scientifici Maugeri SpA · NCT05720780 · Data updated 2026-11-12

This study tests if adding music to rehabilitation training can help people with COPD and chronic respiratory failure exercise better and feel less short of breath.

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment156 (estimated)
SponsorIstituti Clinici Scientifici Maugeri SpA
Academic / other
Locations6 sites (Telese Terme, Benevento and 5 other locations)
StatusRecruiting
StartedJanuary 26, 2023
Main results expectedDecember 31, 2026
Study endsApril 30, 2027
Registry record updatedFebruary 23, 2026
Trial IDNCT05720780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with COPD and chronic respiratory failure who are clinically stable and have been on long-term oxygen therapy.

Probably not a fit

Patients with cognitive impairments, active infections, or other significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of incorporating music as a distracting auditory stimulus during rehabilitation training for patients with Chronic Obstructive Pulmonary Disease (COPD) and chronic respiratory failure (CRF). The study aims to compare exercise capacity, endurance, and perception of dyspnea between a group receiving music-supported training and a control group undergoing standard rehabilitation without music. By utilizing music therapy techniques, the trial seeks to enhance the psychological and physiological outcomes of rehabilitation. Participants will be monitored for improvements in exercise tolerance and overall quality of life.

Why it matters

Potential benefit: If successful, this approach could significantly improve exercise capacity and quality of life for patients with COPD and CRF.

How similar studies have gone: Previous studies have shown promising results with music therapy in rehabilitation contexts, suggesting potential for success in this novel application for COPD patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of COPD (Forced expiratory volume in 1 second / post-bronchodilator forced vital capacity \< 0.7) without functional reversibility
* Chronic respiratory failure with stable hypoxia (PaO2 \< 60 mmHg in room air)
* Long Term Oxygen Therapy (LTOT) for at least 3 months
* Clinical stability: pH range 7.38-7.42, with no recent exacerbations in the last 7 days and no changes in drug therapy in the previous 7 days

Exclusion Criteria:

* Non-invasive ventilation at home
* Cognitive impairment (Mini-Mental State Examination Score \< 22)
* Asthma or evidence of bronchodilator response
* Pulmonary fibrosis
* Obstructive sleep apnea syndrome
* Lung cancer
* Active microbial infections
* Neuromuscular, orthopedic, and/or medical conditions that preclude testing
* Pulmonary rehabilitation program in the previous 6 months

Where it's running

  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Lumezzane
    Lumezzane, Brescia, Italy
    Recruiting
  • ICS Maugeri IRCCS, respiratory rehabilitation of the Institute of Montescano
    Montescano, Pavia, Italy
    Recruiting
  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Tradate
    Tradate, Varese, Italy
    Recruiting
  • ICS Maugeri IRCCS, Respiratory rehabilitation of the Institute of Pavia
    Pavia, Italy
    Recruiting
  • ICS Maugeri IRCCS, respiratory rehabilitation of the Institute of Telese
    Telese Terme, Benevento, Italy
    Not yet recruiting
  • ICS Maugeri IRCCS, respiratory rehabilitation of the Institute of Bari
    Bari, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

    This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

    Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

  • Cognitive load and inhaler technique in COPD

    This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

    Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

  • Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

    A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

    Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

  • Continuous vs High-Intensity Interval Exercise in COPD

    This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

    Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

  • Biomarker clues for COPD, IPF, and lung cancer

    This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

  • HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

    This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

    Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.